AU2624299A - Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy - Google Patents
Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapyInfo
- Publication number
- AU2624299A AU2624299A AU26242/99A AU2624299A AU2624299A AU 2624299 A AU2624299 A AU 2624299A AU 26242/99 A AU26242/99 A AU 26242/99A AU 2624299 A AU2624299 A AU 2624299A AU 2624299 A AU2624299 A AU 2624299A
- Authority
- AU
- Australia
- Prior art keywords
- pharmacotherapy
- necrosis
- utilization
- order
- produce preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3008598A | 1998-02-25 | 1998-02-25 | |
US09030085 | 1998-02-25 | ||
PCT/EP1999/001048 WO1999043317A1 (en) | 1998-02-25 | 1999-02-22 | Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2624299A true AU2624299A (en) | 1999-09-15 |
Family
ID=21852412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26242/99A Abandoned AU2624299A (en) | 1998-02-25 | 1999-02-22 | Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2624299A (en) |
DE (1) | DE19824653A1 (en) |
WO (1) | WO1999043317A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062551A1 (en) * | 1998-06-05 | 1999-12-09 | Board Of Regents, The University Of Texas System | Texaphyrin conjugates and uses thereof |
DE19835082A1 (en) * | 1998-07-24 | 2000-02-03 | Schering Ag | Paramagnetic 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical compositions containing them, processes for their preparation and their use for necrosis and infarct MR imaging |
US6251367B1 (en) | 1998-07-24 | 2001-06-26 | Schering Aktiengesellschaft | Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction |
US7097826B2 (en) * | 1999-12-23 | 2006-08-29 | Health Research, Inc. | Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
US7087214B2 (en) * | 2002-02-01 | 2006-08-08 | Zentaris Gmbh | Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
FR2867189A1 (en) * | 2004-03-08 | 2005-09-09 | Ludovic Bourre | New compound comprising protein kinase regulator and photoactivatable molecule, useful for treating protein kinase-related diseases, e.g. tumors and inflammation |
GB0723124D0 (en) | 2007-11-26 | 2008-01-02 | Univ Leuven Kath | Targeted radiotherapy |
CN115746007A (en) * | 2022-12-02 | 2023-03-07 | 无锡市南京大学锡山应用生物技术研究所 | Compound capable of activating STING pathway as radiotherapy sensitizer and other applications thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL91933A (en) * | 1988-10-11 | 1994-12-29 | Univ Southern California | Vasoactive immunoconjugates useful for increasing the vascular permeability or the blood supply to neoplastic or otherwise diseased tissues |
US5457183A (en) * | 1989-03-06 | 1995-10-10 | Board Of Regents, The University Of Texas System | Hydroxylated texaphyrins |
US5222134A (en) * | 1990-11-07 | 1993-06-22 | Tau Systems Corporation | Secure system for activating personal computer software at remote locations |
DE4305523A1 (en) * | 1993-02-17 | 1994-08-18 | Diagnostikforschung Inst | Meso-tetraphenylporphyrin complexes, processes for their preparation and pharmaceutical compositions containing them |
WO1995031219A1 (en) * | 1994-05-11 | 1995-11-23 | Schering Aktiengesellschaft | The use of porphyrin-complex or expanded porphyrin-complex compounds as localization diagnosticum for infarction or necrosis |
US5834503A (en) * | 1996-06-14 | 1998-11-10 | Qlt Phototherapeutics, Inc. | Methods to treat arterial plaque |
-
1998
- 1998-05-25 DE DE19824653A patent/DE19824653A1/en not_active Withdrawn
-
1999
- 1999-02-22 AU AU26242/99A patent/AU2624299A/en not_active Abandoned
- 1999-02-22 WO PCT/EP1999/001048 patent/WO1999043317A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
DE19824653A1 (en) | 1999-08-26 |
WO1999043317A1 (en) | 1999-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2168597A (en) | Improvements in or relating to encapsulation | |
AU1407699A (en) | Distributed architecture utility | |
AU1884797A (en) | Improvements in or relating to contrast agents | |
AU4714797A (en) | Improvements in or relating to contrast agents | |
AU2553499A (en) | Improvements in and relating to recreational devices | |
AU2546399A (en) | Preparations with controlled release | |
AU2846699A (en) | Improvements in or relating to enclosures | |
AU4636699A (en) | Materials and methods relating to encapsulation | |
AU2624299A (en) | Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy | |
AU2538500A (en) | Organo-phosphorus compounds and their utilization | |
AU6519899A (en) | Improvements in and relating to emitters | |
AU8228498A (en) | Improvements in and relating to durometers | |
AU3617799A (en) | Improvements in or relating to contrast agents | |
AU1577900A (en) | Improvements in or relating to pipes | |
AU9359098A (en) | Improvements in or relating to chairs | |
AU8736598A (en) | Improvements in and relating to compounds and complexes | |
AU1636597A (en) | Improvements in or relating to valves | |
AUPP368498A0 (en) | Improvements in decals | |
AUPP707398A0 (en) | Improvements in or relating to balustrading | |
AUPO614497A0 (en) | Improvements in or relating to supports for structures | |
AU6188198A (en) | Improvements in or relating to supports for structures | |
AUPP679898A0 (en) | Improvements in utility folders | |
AUPO693597A0 (en) | Improvements in decals | |
AUPN998596A0 (en) | Improvements in decals | |
AUPO642597A0 (en) | Improvements in push-chairs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |